Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile4 entries
2024
Court allows Allergan trade-secrets claims against Revance to proceed
Ruling
In Allergan’s trade-secrets lawsuit against competitor Revance, the court denied Revance’s motion to dismiss, finding that alleged access to and similarity involving trade secrets plausibly supported the claims. These are allegations, not a finding of liability.
Source excerpt
The court inferred use of the trade secrets based on access and similarity.
District Judge Eli Richardson disagreed, denying Revance’s motion to dismiss.
2022
Teva and Allergan reach San Francisco opioid settlement
Settlement
Teva Pharmaceutical Industries and AbbVie's Allergan unit reached a $58 million settlement with San Francisco over claims that they fueled the city's opioid epidemic. Teva will pay $25 million and contribute a $20 million supply of Narcan; AbbVie will pay $13 million. Neither Teva nor Allergan admitted wrongdoing.
Stated objective. Resolve claims and avert a trial next month.
Company response
Denial — CVS Health Corp, Teva Pharmaceutical Industries Ltd, Abbvie Inc's Allergan unit, and Endo International Plc
The four companies denied wrongdoing in agreeing to settle.
Source excerpt
Neither Teva nor Allergan admitted wrongdoing as part of the settlement
Under the deal announced by City Attorney David Chiu, Israel-based Teva will pay $25 million in cash and contribute a $20 million supply of the overdose-reversal drug Narcan. AbbVie will pay $13 million.
The four companies denied wrongdoing in agreeing to settle.
2022
Minnesota states reach tentative opioid settlement with Allergan
Settlement
Minnesota Attorney General Keith Ellison announced that multiple states had reached a tentative $2.37 billion settlement agreement with Allergan. The final terms still needed to be reached. Ellison alleged that the companies caused death and destruction by putting profits before people's lives.
Source excerpt
Friday morning, Minnesota Attorney General Keith Ellison announced multiple states had reached a tentative $2.37 billion agreement with Allergan.
Even so, I have and will continue to aggressively hold these companies accountable for the harm they’ve caused in order to protect the people of Minnesota.
Drug manufacturer Allergan has agreed to pay Suffolk and Nassau counties and the state of New York up to $200 million for its role in the opioid epidemic.
2018
Opioid-related litigation
Allergan was named alongside other pharmaceutical manufacturers and distributors in lawsuits filed by U.S. states and municipalities concerning the opioid epidemic. The litigation addressed alleged roles in the manufacture, marketing or distribution of opioids; the proceedings formed part of broader national opioid litigation.